ADVANCED UROTHELIAL CANCER
Clinical trials for ADVANCED UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to tame Chemo's nerve damage in bladder cancer
Symptom relief Recruiting nowThis early-phase study tests an investigational drug called GB-4362 given alongside standard treatments (enfortumab vedotin and pembrolizumab) for adults with advanced or metastatic urothelial cancer. The goal is to see if GB-4362 can safely neutralize a chemotherapy byproduct th…
Matched conditions: ADVANCED UROTHELIAL CANCER
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to crack the code on cancer drug resistance
Knowledge-focused Recruiting nowThis study looks at how well certain markers in tumors can predict whether a type of targeted cancer treatment called antibody-drug conjugates (ADCs) will work. About 400 adults with advanced breast, stomach, bladder, or lung cancer will provide tumor samples before and after tre…
Matched conditions: ADVANCED UROTHELIAL CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC